Depixus Revenue and Competitors
Estimated Revenue & Valuation
- Depixus's estimated annual revenue is currently $11.5M per year.
- Depixus's estimated revenue per employee is $155,000
Employee Data
- Depixus has 74 Employees.
- Depixus grew their employee count by 6% last year.
Depixus's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Head Applications and Collaborations | Reveal Email/Phone |
Depixus Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $12.6M | 81 | -5% | N/A | N/A |
#2 | $19.5M | 126 | -2% | N/A | N/A |
#3 | $36.3M | 234 | 22% | N/A | N/A |
#4 | $19.7M | 127 | -17% | N/A | N/A |
#5 | $14.3M | 92 | 0% | $179.5M | N/A |
#6 | $49.4M | 208 | -8% | €201.1M | N/A |
#7 | $44.5M | 287 | -3% | N/A | N/A |
#8 | $7.6M | 49 | N/A | N/A | N/A |
#9 | $6.4M | 41 | N/A | N/A | N/A |
#10 | $17.2M | 111 | -15% | N/A | N/A |
What Is Depixus?
Depixus (formerly PicoSeq) is undertaking commercial development of a disruptive new technology for the fast, accurate, and inexpensive extraction of sequence and epigenetic information from long individual molecules of DNA and RNA. Our MAGNA technology goes beyond decoding the static genetic code to reveal the dynamics of the genome that control health and disease.
keywords:N/A
N/A
Total Funding
74
Number of Employees
$11.5M
Revenue (est)
6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Depixus News
2022-03-22 - Depixus Seeks to Commercialize 'Magnetic Tweezers' for Drug ...
NEW YORK Depixus, a startup with operations on both sides of the English Channel, is working on commercializing technology that it says...
Other Companies in Paris
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $18M | 74 | 3% | N/A |
#2 | $9.7M | 74 | -5% | N/A |
#3 | $15.1M | 74 | 37% | N/A |
#4 | $9.7M | 74 | 19% | N/A |
#5 | $16.7M | 74 | 16% | N/A |